Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ClearPoint Neuro Inc.

    NASDAQ: CLPT · Real-Time Price · USD
    11.60
    0.06 (0.52%)
    At close: Jun 16, 2025, 3:59 PM
    12.10
    4.31%
    After-hours: Jun 16, 2025, 07:31 PM EDT

    ClearPoint Neuro Statistics

    Share Statistics

    ClearPoint Neuro has 28.27M shares outstanding. The number of shares has increased by 0.77% in one year.

    Shares Outstanding

    n/a
    		 28.27M

    Shares Change (YoY)

    n/a
    		 0.77%

    Shares Change (QoQ)

    n/a
    		 0.17%

    Owned by Institutions (%)

    n/a
    		 27.56%

    Shares Floating

    n/a
    		 24.19M

    Failed to Deliver (FTD) Shares

    n/a
    		 897

    FTD / Avg. Volume

    n/a
    		 0.33%

    Short Selling Information

    The latest short interest is 1.08M, so 3.81% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.08M

    Short % of Shares Out

    n/a
    		 3.81%

    Short % of Float

    n/a
    		 3.94%

    Short Ratio (days to cover)

    n/a
    		 5.03

    Valuation Ratios

    The PE ratio is -21.98 and the forward PE ratio is -17.48. ClearPoint Neuro's PEG ratio is 0.99.

    PE Ratio

    n/a
    		 -21.98

    Forward PE

    n/a
    		 -17.48

    PS Ratio

    n/a
    		 13.24

    Forward PS

    n/a
    		 4.4

    PB Ratio

    n/a
    		 16.37

    P/FCF Ratio

    n/a
    		 -45.06

    PEG Ratio

    n/a
    		 0.99
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for ClearPoint Neuro.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.14.

    Current Ratio

    n/a
    		 3.22

    Quick Ratio

    n/a
    		 2.56

    Debt / Equity

    n/a
    		 0.14

    Debt / EBITDA

    n/a
    		 -0.2

    Debt / FCF

    n/a
    		 -0.39

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $272,956.52

    Profits Per Employee

    n/a
    		 $-164,469.57

    Employee Count

    n/a
    		 115

    Asset Turnover

    n/a
    		 0.8

    Inventory Turnover

    n/a
    		 1.79

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 115.21% in the last 52 weeks. The beta is 0.94, so ClearPoint Neuro's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.94

    52-Week Price Change

    n/a
    		 115.21%

    50-Day Moving Average

    n/a
    		 12.76

    200-Day Moving Average

    n/a
    		 13.57

    Relative Strength Index (RSI)

    n/a
    		 40.6

    Average Volume (20 Days)

    n/a
    		 270,444

    Income Statement

    In the last 12 months, ClearPoint Neuro had revenue of 31.39M and earned -18.91M in profits. Earnings per share was -0.7.

    Revenue

    n/a
    		 31.39M

    Gross Profit

    n/a
    		 19.12M

    Operating Income

    n/a
    		 -19.75M

    Net Income

    n/a
    		 -18.91M

    EBITDA

    n/a
    		 -17.84M

    EBIT

    n/a
    		 -19.75M

    Earnings Per Share (EPS)

    n/a
    		 -0.7
    Full Income Statement

    Balance Sheet

    The company has 20.1M in cash and 3.57M in debt, giving a net cash position of 16.54M.

    Cash & Cash Equivalents

    n/a
    		 20.1M

    Total Debt

    n/a
    		 3.57M

    Net Cash

    n/a
    		 16.54M

    Retained Earnings

    n/a
    		 -191.37M

    Total Assets

    n/a
    		 30.07M

    Working Capital

    n/a
    		 17.35M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -8.95M and capital expenditures -275K, giving a free cash flow of -9.22M.

    Operating Cash Flow

    n/a
    		 -8.95M

    Capital Expenditures

    n/a
    		 -275K

    Free Cash Flow

    n/a
    		 -9.22M

    FCF Per Share

    n/a
    		 -0.34
    Full Cash Flow Statement

    Margins

    Gross margin is 60.92%, with operating and profit margins of -62.91% and -60.25%.

    Gross Margin

    n/a
    		 60.92%

    Operating Margin

    n/a
    		 -62.91%

    Pretax Margin

    n/a
    		 -60.25%

    Profit Margin

    n/a
    		 -60.25%

    EBITDA Margin

    n/a
    		 -56.84%

    EBIT Margin

    n/a
    		 -62.91%

    FCF Margin

    n/a
    		 -29.39%

    Dividends & Yields

    CLPT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CLPT is $28, which is 141.4% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $28

    Price Target Difference

    n/a
    		 141.4%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 27, 2016. It was a backward split with a ratio of 1:40.

    Last Split Date

    n/a
    		 Jul 27, 2016

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:40

    Scores

    Altman Z-Score

    n/a
    		 10.53

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist